Wednesday, November 3, 2004

American Generics Labs Introduces New Ephedra-Based Product Line

American Generics Labs Introduces New Ephedra-Based Product Line

American Generic Laboratories LLC of Salt Lake City Utah (www. americangenericlabs. com) has launched four new Ephedra based dietary supplements that will be made available for retail purchase in early November.

Salt Lake City, UT (PRWEB) November 16, 2005

American Generic Laboratories LLC of Salt Lake City Utah (www. americangenericlabs. com) has launched four new Ephedra based dietary supplements that will be made available for retail purchase in early November. The four new products; Superdrine RX-10TM, Ripped Power TM, Metabothin TM and Super Ephedra Extreme TM have been introduced to the market as a result of high consumer demand following the recent overturning of the 2004 FDA ban on Ephedra based products.

The company hopes to capture the 14,000,000-17,000,000 U. S ephedra consumers that existed prior to the erroneous banning of the herb. It is estimated that Americans consumed in excess of 3 billion yearly doses of ephedra based products.

Ephedra, also called Ma huang, is a naturally occurring substance derived from plants. Its main active ingredients are ephedra alkaloids. In recent years, ephedra based products have been used extensively by consumers to enhance sports performance, aid in dieting and weight loss, and to increase energy.

In December 2003, the FDA issued a consumer alert warning of the potential health risks and on the safety of dietary supplements containing ephedra. The alert advised consumers to immediately stop buying and using ephedra products. The final rule published in April of 2004 banned the sale of ephedra based products.

In April 2005, that rule was overturned by a US Federal District Court. The Court found that the FDA’s ban on Ephedra at any dose was not legal. The Court also found that the FDA did not provide enough scientific evidence and did not meet its burden of proof in banning the herb to begin with.

American Generic Labs produces the most successful Ephedra formulations currently available. The products are manufactured in FDA approved facilities and are of daily dosages permitted by law. All products are manufactured with child resistant safety caps and meet requirements for adverse reaction reporting.

For more information please visit American Generic Lab’s website (www. americangenericlabs. com)

# # #